Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo

<p>Abstract</p> <p>Background</p> <p>Glioblastoma is the most common and most aggressive form of malignant glioma and is very difficult to treat. Controlling tumour cell invasion and angiogenesis is essential to improve the prognosis of glioblastoma patients. Since cons...

Full description

Bibliographic Details
Main Authors: Nakabayashi Hiromichi, Shimizu Keiji
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/453
_version_ 1831689385153658880
author Nakabayashi Hiromichi
Shimizu Keiji
author_facet Nakabayashi Hiromichi
Shimizu Keiji
author_sort Nakabayashi Hiromichi
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Glioblastoma is the most common and most aggressive form of malignant glioma and is very difficult to treat. Controlling tumour cell invasion and angiogenesis is essential to improve the prognosis of glioblastoma patients. Since constitutive activation of nuclear factor-κB (NF-κB) is necessary for tumour progression, NF-κB may be an important pharmacological target for this disease. Our study aimed to evaluate the antitumour effects of parthenolide, a NF-κB inhibitor, in two human glioblastoma cell lines (U87MG and U373) and in glioblastoma xenografts. Furthermore, we aimed to investigate the molecular mechanisms underlying these effects.</p> <p>Methods</p> <p>The anti-invasive and anti-angiogenic effects of parthenolide were analysed using in vitro invasion and angiogenesis assays. Parthenolide-induced growth inhibition of glioblastoma cells in vitro was determined using the MTT (methyl thiazolyl tetrazolium) assay. In addition, the effect of parthenolide on orthotropic implantation in vivo was evaluated using an intracerebral human glioblastoma xenograft model.</p> <p>Results</p> <p>We found that parthenolide suppresses proliferation, invasion, and tumour- induced angiogenesis of glioblastoma cells. Molecular studies demonstrated that parthenolide suppresses gene and protein expression of angiogenic factors. Furthermore, parthenolide reduced Akt phosphorylation and activated mitochondrial signalling, suggesting that the antitumour function of parthenolide may be mediated not only by the inhibition of NF-κB but also by the inhibition of Akt signalling and the activation of apoptotic proteins. Parthenolide suppressed neovascularity and tumour growth in glioblastoma xenografts.</p> <p>Conclusion</p> <p>The present study identified parthenolide as a new therapeutic agent for glioblastomas.</p>
first_indexed 2024-12-20T10:48:30Z
format Article
id doaj.art-575ff8feab144b06b8cf56f83cf62764
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-20T10:48:30Z
publishDate 2012-10-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-575ff8feab144b06b8cf56f83cf627642022-12-21T19:43:20ZengBMCBMC Cancer1471-24072012-10-0112145310.1186/1471-2407-12-453Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivoNakabayashi HiromichiShimizu Keiji<p>Abstract</p> <p>Background</p> <p>Glioblastoma is the most common and most aggressive form of malignant glioma and is very difficult to treat. Controlling tumour cell invasion and angiogenesis is essential to improve the prognosis of glioblastoma patients. Since constitutive activation of nuclear factor-κB (NF-κB) is necessary for tumour progression, NF-κB may be an important pharmacological target for this disease. Our study aimed to evaluate the antitumour effects of parthenolide, a NF-κB inhibitor, in two human glioblastoma cell lines (U87MG and U373) and in glioblastoma xenografts. Furthermore, we aimed to investigate the molecular mechanisms underlying these effects.</p> <p>Methods</p> <p>The anti-invasive and anti-angiogenic effects of parthenolide were analysed using in vitro invasion and angiogenesis assays. Parthenolide-induced growth inhibition of glioblastoma cells in vitro was determined using the MTT (methyl thiazolyl tetrazolium) assay. In addition, the effect of parthenolide on orthotropic implantation in vivo was evaluated using an intracerebral human glioblastoma xenograft model.</p> <p>Results</p> <p>We found that parthenolide suppresses proliferation, invasion, and tumour- induced angiogenesis of glioblastoma cells. Molecular studies demonstrated that parthenolide suppresses gene and protein expression of angiogenic factors. Furthermore, parthenolide reduced Akt phosphorylation and activated mitochondrial signalling, suggesting that the antitumour function of parthenolide may be mediated not only by the inhibition of NF-κB but also by the inhibition of Akt signalling and the activation of apoptotic proteins. Parthenolide suppressed neovascularity and tumour growth in glioblastoma xenografts.</p> <p>Conclusion</p> <p>The present study identified parthenolide as a new therapeutic agent for glioblastomas.</p>http://www.biomedcentral.com/1471-2407/12/453ParthenolideGlioblastomaNF-κBInvasionAngiogenesis
spellingShingle Nakabayashi Hiromichi
Shimizu Keiji
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
BMC Cancer
Parthenolide
Glioblastoma
NF-κB
Invasion
Angiogenesis
title Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
title_full Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
title_fullStr Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
title_full_unstemmed Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
title_short Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
title_sort involvement of akt nf κb pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
topic Parthenolide
Glioblastoma
NF-κB
Invasion
Angiogenesis
url http://www.biomedcentral.com/1471-2407/12/453
work_keys_str_mv AT nakabayashihiromichi involvementofaktnfkbpathwayinantitumoreffectsofparthenolideonglioblastomacellsinvitroandinvivo
AT shimizukeiji involvementofaktnfkbpathwayinantitumoreffectsofparthenolideonglioblastomacellsinvitroandinvivo